PROTEIN DESIGN LABS INC 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-05-26 4:34 pm Sale |
2020-05-21 | 13D | Evofem Biosciences, Inc. EVFM |
PROTEIN DESIGN LABS INC PDLI |
1,778 6.300% |
-7,111 (-80.00%) |
Filing |